Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 2.2B | 2.6B | 2.1B | 2.4B |
| Cost of revenue | 1.3B | 1.5B | 1.3B | 1.5B |
| Gross profit | 913M | 1.1B | 868M | 979M |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | — | — | — | — |
| Other operating expenses | 253M | 249M | 215M | 237M |
| Operating income | 37M | 178M | 115M | 147M |
| Non operating interest income | ||||
| Income | 20M | 5M | 5M | 6M |
| Expense | 35M | 45M | 42M | 42M |
| Other income expense | — | — | — | — |
| Pretax income | 22M | 138M | 78M | 111M |
| Tax provision | 5M | 29M | 18M | 24M |
| Net income | 17M | 109M | 60M | 87M |
| Basic EPS | 0.3 | 2.1 | 1.2 | 1.7 |
| Diluted EPS | 0.3 | 2.1 | 1.2 | 1.7 |
| Basic average shares | 50M | 50M | 50M | 50M |
| Diluted average shares | 50M | 50M | 50M | 50M |
| EBITDA | 213M | 338M | 273M | 306M |
| Net income from continuing op. | 22M | 138M | 78M | 111M |
| Minority interests | 0 | -3M | 0 | -2M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |